Life Sciences Times

NextPoint Therapeutics Chief Executive Officer Ivan Cheung Named to the 2024 TIME100 Health List

May 6, 2024

Life Science Firm Cell Signaling Technology and HGA Unveil Plans for a Research and Innovation Campus in Manchester-by-the-Sea

May 2, 2024

908 Devices Acquires RedWave Technology, Expanding its Forensics Product Offering

April 30, 2024

New England Biolabs Leases 28,000 SF

December 7, 2020

Walgreens Boots Alliance Appoints Bryan C. Hanson to Board of Directors

October 28, 2022

Immunology biotech firm to relocate from Cambridge to Woburn

November 18, 2021

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Life Sciences Times

TOP AUTHORS

Most Read

HTL Biotechnology, market leader in biopolymers, acquires the Modern Meadow’s human recombinant collagen platform for beauty and biomedical applications

Ratio Therapeutics Appoint Marc Becker as Chief Financial Officer and Chief Operating Officer

Steward Health Care Finalizing Financing Deal With Medical Properties Trust to Support Its Restructuring

NextPoint Therapeutics Chief Executive Officer Ivan Cheung Named to the 2024 TIME100 Health List

EDITOR PICKS

NextPoint Therapeutics Chief Executive Officer Ivan Cheung Named to the 2024 TIME100 Health List

Life Science Firm Cell Signaling Technology and HGA Unveil Plans for a Research and Innovation Campus in Manchester-by-the-Sea

908 Devices Acquires RedWave Technology, Expanding its Forensics Product Offering

POPULAR POSTS

New England Biolabs Leases 28,000 SF

Walgreens Boots Alliance Appoints Bryan C. Hanson to Board of Directors

Immunology biotech firm to relocate from Cambridge to Woburn

POPULAR CATEGORY

ABOUT US

FOLLOW US